Revolutionary diagnostic blood test for Alzheimer’s

15 May, 2024

Wallenberg Clinical Scholar Oskar Hansson has researched Alzheimer’s disease for just over twenty years. He has developed a number of methods for earlier, more accurate diagnosis. His team has been essential for the development of simple blood tests for the disease. Read more at Knut and Alice Wallenberg Foundation  

Read the article

Research into methods for diagnosing Alzheimer’s receives SEK 10 million from the Torsten Söderberg Foundation

22 February, 2024

Finding a safe and simple way to diagnose Alzheimer’s disease in primary healthcare has long been a dream. This year’s recipient of the Torsten Söderberg Academy Professorship in Medicine, Oskar Hansson, Professor of Neurology at Lund University, is well on the way to making this reality. Read more at: The Royal Swedish Academy of Sciences

Read the article

New blood marker can identify Parkinsonian diseases

19 September, 2023

Is it possible that a single biomarker can detect all types of diseases related to dopamine deficiency in the brain? Yes, that’s what a research group in Lund is discovering. “We have observed that an enzyme in cerebrospinal fluid and in blood is a useful marker for identifying all types of Parkinson’s-related diseases with high

Read the article

Lewy body disease can be detected before symptoms

18 July, 2023

Lewy body disease is the second most common neurodegenerative disease after Alzheimer’s disease. A research group from Lund University has now shown that the disease can be detected before symptoms appear, using a spinal fluid test. The studies are published in Nature Medicine, where the researchers also demonstrate that reduced sense of smell is strongly

Read the article

ERC Advanced Grant for Alzheimer’s Research

3 June, 2023

Three researchers at Lund University in Sweden, all with a long list of significant research credentials, have been awarded the ERC Advanced Grant worth EUR 2.5 million each to further develop and advance their research projects. One of these researchers is neuroscientist Oskar Hansson, who will use blood tests for rapid screening of drugs in

Read the article

Triple success in prestigious EU grant round

30 March, 2023

Three researchers at Lund University in Sweden, all with a long list of significant research credentials, have been awarded the ERC Advanced Grant worth EUR 2.5 million each to further develop and advance their research projects. This concerns research on a fundamentally changed food system, chaperone proteins’ function in neurodegenerative diseases, and blood tests for

Read the article

Optimal blood tests for development of new therapies of Alzheimer’s disease

3 January, 2023

A new study have identified which blood tests are best at detecting Alzheimer’s disease during the earliest stages, and also another blood test that is optimal for detecting relevant treatment effects. These findings will speed up the development of new therapies that can slow down the disease progression. Read more at: Multipark, Lund University

Read the article

The brain’s immune cells can be triggered to slow down Alzheimer’s disease

29 November, 2022

The brain’s big-eating immune cells can slow down the progression of Alzheimer’s disease. This is shown by a study that is now published in Nature Aging. The brain’s own immune cells are called microglia and are found in the central nervous system. They are big eaters that kill viruses, damaged cells and infectious agents they

Read the article

Alzheimer’s disease can be diagnosed before symptoms emerge

11 November, 2022

A large study led by Lund University in Sweden has shown that people with Alzheimer’s disease can now be identified before they experience any symptoms. It is now also possible to predict who will deteriorate within the next few years. The study is published in Nature Medicine, and is very timely in light of the

Read the article

MultiPark researcher with Bill Gates in Brussels

7 November, 2022

MultiPark’s scientists conduct world-leading research in biomarkers for Alzheimer’s disease, led by Professor Oskar Hansson at the memory clinic at Skåne University Hospital. He recently met with Bill Gates to discuss the future possibilities in this field. Read more at: MultiPark, Lund University

Read the article

MultiPark researcher behind Alzheimer’s Association Recommendations about use of Alzheimer’s “Blood Tests”

12 September, 2022

Alzheimer’s Association recently released recommendations about using blood-based biomarkers to detect Alzheimer’s disease. The recommendations are based on research conducted by Oskar Hansson, one of MultiPark’s research group leaders. “Blood-based biomarkers for Alzheimer’s are already improving the design of clinical trials, and they are very likely to revolutionize the diagnosis of Alzheimer’s in the future,”

Read the article

Large EU project on Alzheimer’s coordinated by Lund University

17 November, 2021

With the support of an EU grant of 1.9 million euros, Alzheimer’s researcher Oskar Hansson will lead and coordinate a research collaboration between Sweden, Spain, France, Germany and Denmark. The goal is to create conditions for early and correct diagnosis of Alzheimer’s disease. This is to improve the treatment and care of the patients and

Read the article

Förbättrad diagnostik av Alzheimers sjukdom belönas med Svenska Läkaresällskapets Jubileumspris

29 September, 2021

Oskar Hansson belönas för sin forskning som bland annat visat på att nya blodmarkörer kan avsevärt förbättra diagnostiken av Alzheimers sjukdom. På sikt kommer detta hjälpa patienter runt världen med att få en riktig diagnos och därmed korrekt behandling och vård. Läs mer här

Read the article

They want to solve the mystery of Alzheimer’s

16 December, 2020

She’s a chemist. He’s a medic. Together, they stand behind some of the recent major research breakthroughs on Alzheimer’s disease. Sara Linse and Oskar Hansson is now laying the foundation for future drugs and diagnostic methods. It is such an unusual morning in late November when the sun does not have to fight against the

Read the article